The Effects of Lowering Dietary Carbohydrates on Health, Exercise Performance and Wellbeing-related Outcomes

January 22, 2021 updated by: University of Ostrava
The aim of the study is to investigate the long-term effects of the ketogenic diet and exercise (including interactions) on health markers, exercise performance and wellbeing outcomes in sedentary overweight individuals.

Study Overview

Status

Completed

Detailed Description

Intentional nutritional ketosis induced by the low carbohydrate diet is an intensively discussed topic of many scientific as well as non-scientific discussions throughout the areas of healthy living, the sports sciences and often used now for the prevention and treatment of chronic diseases. It has been demonstrated that long-term low-carbohydrate diet is more effective for weight loss and cardiovascular and metabolic risk factor reduction than a low-fat diet. In light of conflicting theories of best practice surrounding a polarized topic that impacts human health and daily work performance, the primary aim of this research project is to examine how low-carbohydrate ketogenic diets affect health markers, exercise performance and wellbeing outcomes in sedentary overweight individuals. Each study subject will be randomized into one of the four arms of the study and will undergo a 12-week intervention, with the exception of the study subjects in the control group, who will undergo no intervention for the period of 12 weeks.

The project outcomes are of immense importance for the investigator's global human health, focus on a unique holistic perspective and have the potential to contribute towards much-needed adjustments in public health recommendations.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Moravian-Silesian Region
      • Ostrava, Moravian-Silesian Region, Czechia, 70103
        • University of Ostrava

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI 25.00 - 40.00 kg/m2
  • non-smokers
  • non-excessive alcohol intake (self-reported, ≥ to 2 drinks/day for men or ≥1 drink/day for women)
  • willing to accept random assignment
  • low active individuals over the last 1 year, i.e. no specific sports training or regular exercise (up to once a week) and self-reported physical activity < 150 min/week (IPAQ)
  • no evidence of liver, renal, metabolic, and cardiopulmonary disease and dis-eases contraindicating physical activity, no cancer, no psychiatric illness
  • Physical Activity Readiness Questionnaire (PAR-Q) pass
  • body weight stable for the last 2 months and not actively on a weight loss plan
  • prediabetes state allowed (impaired fasting glucose level, i.e. 5.6 - 6.9 mmol/l; HbA1c 5.7 - 6.4 %)

Exclusion Criteria:

  • pregnancy, lactation
  • any specific diet (e.g. vegetarian)
  • use of hypoglycemic, lipid-lowering, antihypertensive, psychiatric medications or medications known to affect body weight or energy expenditure; any medication not noted allowed if the individual had been stable while taking such medication for at least 3 months prior to baseline data collection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ketogenic diet

Ketogenic diet:

  • < 50 g carbohydrates - CHO/d (based on the 1-week pre-intervention habitual diet monitoring)
  • protein restriction ≤ 1.5 g/kg free-fat mass (FFM)/day.
  • fat type intake recommendation:
  • natural fats
  • trans-FA reduction
The study subjects randomized for this intervention will observe the ketogenic diet, as prescribed by the protocol.
Experimental: Exercise HIIT (High-Intensity Interval Training)

Exercise intervention:

- HIIT: 5 min warm-up - slow walking, 3 min interval of high-intensity walking (above VT2), 3 min interval of low-intensity walking (40 % VO2peak); 5 min cool-down - slow walking:

Cycle 1

  • week 1-3 - 3 sessions/week, total time 31 min/session (4 intervals)
  • week 4 - regeneration: only 2 sessions with 2 intervals, keep total time 31 min/session, (+ GXT)

Cycle 2

  • week 5-7 - 3 sessions/week, total time 43 min/session (6 intervals)
  • week 8 - regeneration: only 2 sessions with 4 intervals, total time 31 min/session, (+ GXT)

Cycle 3

  • week 9-11 - 3 sessions/week, total time 55 min/session (8 intervals)
  • week 12 - regeneration: only 2 sessions with 6 intervals, total time 43min/session, (+GXT)
The study subjects randomized for this intervention will observe the HIIT exercise programme, as prescribed by the protocol.
Experimental: Ketogenic diet + Exercise HIIT

Ketogenic diet:

  • < 50 g carbohydrates - CHO/d (based on the 1-week pre-intervention habitual diet monitoring)
  • protein restriction ≤ 1.5 g/kg free-fat mass (FFM)/day.
  • fat type intake recommendation:
  • natural fats
  • trans-FA reduction

Exercise intervention:

- HIIT: 5 min warm-up - slow walking, 3 min interval of high-intensity walking (above VT2), 3 min interval of low-intensity walking (40 % VO2peak); 5 min cool-down - slow walking:

Cycle 1

  • week 1-3 - 3 sessions/week, total time 31 min/session (4 intervals)
  • week 4 - regeneration: only 2 sessions with 2 intervals, keep total time 31 min/session, (+ GXT)

Cycle 2

  • week 5-7 - 3 sessions/week, total time 43 min/session (6 intervals)
  • week 8 - regeneration: only 2 sessions with 4 intervals, total time 31 min/session, (+ GXT)

Cycle 3

  • week 9-11 - 3 sessions/week, total time 55 min/session (8 intervals)
  • week 12 - regeneration: only 2 sessions with 6 intervals, total time 43min/session, (+GXT)
The study subjects randomized for this intervention will observe the ketogenic diet, as prescribed by the protocol.
The study subjects randomized for this intervention will observe the HIIT exercise programme, as prescribed by the protocol.
No Intervention: Control Group
The study subjects in this arm will undergo no dietary changes and no exercise intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the time to exhaustion
Time Frame: 12 weeks (baseline + every four weeks)
All study subjects will undergo the Graded Exercise Test, with measuring of the time to exhaustion in minutes.
12 weeks (baseline + every four weeks)
Change in cardiorespiratory variables - oxygen consumption
Time Frame: 12 weeks (baseline + every four weeks)
All study subjects will undergo the Graded Exercise Test, with measuring of the oxygen consumption (L/min).
12 weeks (baseline + every four weeks)
Change in cardiorespiratory variables - heart rate
Time Frame: 12 weeks (baseline + every four weeks)
All study subjects will undergo the Graded Exercise Test, with measuring of the heart rate (beats per minute).
12 weeks (baseline + every four weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemical analysis - capillary blood
Time Frame: 12 weeks (2 times/week)
All study subjects will undergo biochemical analysis of capillary blood - βHB and fasting glukose in mmol/L.
12 weeks (2 times/week)
Biochemical analysis - venous blood
Time Frame: 12 weeks (2 times/week)
All study subjects will undergo biochemical analysis of venous blood - oxidative stress, inflammation, total CHO, HDL, LDL, TG, FFA, GL, homocysteine, measured in mmol/L.
12 weeks (2 times/week)
Biochemical analysis - venous blood
Time Frame: 12 weeks (2 times/week)
All study subjects will undergo biochemical analysis of venous blood - HBA1c in mmol/mol.
12 weeks (2 times/week)
Anthropometrics - body height
Time Frame: 12 weeks (baseline + every four weeks)
All study subjects will undergo anthropometric assessment of the body height, measured in cm.
12 weeks (baseline + every four weeks)
Anthropometrics - body weight
Time Frame: 12 weeks (baseline + every four weeks)
All study subjects will undergo anthropometric assessment of the body weight, measured in kg.
12 weeks (baseline + every four weeks)
Anthropometrics - waist circumference
Time Frame: 12 weeks (baseline + every four weeks)
All study subjects will undergo anthropometric assessment of the waist circumference, measured in cm.
12 weeks (baseline + every four weeks)
Anthropometrics - DXA
Time Frame: 12 weeks (baseline + outcome)
All study subjects will undergo anthropometric assessment of DXA - total abdominal fat, measured in kg.
12 weeks (baseline + outcome)
InBody (bioimpedance)
Time Frame: 12 weeks (baseline + every four weeks)
All study subjects will undergo antrhropometric assessment of bioimpedance using the InBody device showing the percentage of water and fat in the organism, measured in % of total body weight.
12 weeks (baseline + every four weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lukáš Cipryan, Ass.Prof.,PhDr.,PhD, University of Ostrava

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2018

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

February 15, 2019

First Submitted That Met QC Criteria

April 30, 2019

First Posted (Actual)

May 1, 2019

Study Record Updates

Last Update Posted (Actual)

January 25, 2021

Last Update Submitted That Met QC Criteria

January 22, 2021

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • OU-PdF-GACR-LCHF diet
  • 18-08358S (Other Grant/Funding Number: GACR)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The investigators have not decided to share the individual participant data with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Ketogenic diet

3
Subscribe